back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-10 11:11 Tx date 2025-06-06 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$49,995
+8,431 vol $5.93 each |
39,196 | |
| Filed 2024-12-18 09:23 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,499
+477 vol $5.24 each |
8,970 | |
| Filed 2024-05-13 13:25 Tx date 2024-05-10 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$45,001
+7,576 vol $5.94 each |
30,765 | |
| Filed 2023-05-15 11:48 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
23,189 | |
| Filed 2023-03-19 23:04 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,494
+495 vol $5.04 each |
8,493 | |
| Filed 2023-01-17 17:45 Tx date 2023-01-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,998
+1,883 vol $5.31 each |
7,998 | |
| Filed 2022-05-16 10:04 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
| Filed 2022-04-17 19:16 Tx date 2022-04-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,070
+1,900 vol $5.30 each |
6,115 | |
| Filed 2021-06-18 19:53 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,996
+1,915 vol $5.22 each |
4,215 | |
| Filed 2021-05-24 15:37 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 13:11 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 13:11 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 13:11 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 13:10 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
| Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
| Filed 2021-05-20 11:28 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:28 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 16:15 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-13 15:56 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,120
+2,300 vol $5.27 each |
2,300 | |
| Filed 2021-01-13 15:47 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 16:16 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2020-07-03 16:15 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|